2024-05-08 20:40 | CC:RP | RepliCel Life Sciences Inc (2) | 0.055 | Cease Trade/Suspend Company180 | RepliCel Life Sciences suspended by BCSC |
2024-05-08 08:24 | CC:RP | RepliCel Life Sciences Inc (2) | 0.055 | Halt Trading170 | RepliCel Life Sciences halted at the open |
2024-04-17 20:52 | CC:RP | RepliCel Life Sciences Inc (2) | 0.055 | News Release200 | RepliCel obtains $1-million loan from CEO Schutte |
2024-03-18 12:49 | CC:RP | RepliCel Life Sciences Inc (2) | 0.055 | News Release200 | RepliCel Life signs LOI with CEO for asset purchase |
2024-03-15 11:38 | CC:RP | RepliCel Life Sciences Inc (2) | 0.055 | Halt Trading170 | RepliCel Life Sciences halted at 8:36 a.m. PT |
2024-02-16 14:35 | CC:RP | RepliCel Life Sciences Inc (2) | 0.05 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-02-16 14:30 | CC:RP | RepliCel Life Sciences Inc (2) | 0.05 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-28 18:21 | CC:RP | RepliCel Life Sciences Inc (2) | 0.06 | Miscellaneous270 | RepliCel moved to Tier 2 |
2023-11-28 16:24 | CC:RP | RepliCel Life Sciences Inc (2) | 0.06 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-28 16:22 | CC:RP | RepliCel Life Sciences Inc (2) | 0.06 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-22 15:08 | CC:RP | RepliCel Life Sciences Inc (2) | 0.06 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-22 15:06 | CC:RP | RepliCel Life Sciences Inc (2) | 0.06 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-10-23 19:07 | CC:RP | RepliCel Life Sciences Inc (2) | 0.075 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-10-23 19:05 | CC:RP | RepliCel Life Sciences Inc (2) | 0.075 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-10-16 19:09 | CC:RP | RepliCel Life Sciences Inc (2) | 0.10 | News Release200 | RepliCel receives final award re: Shiseido arbitration |
2023-10-11 19:56 | CC:RP | RepliCel Life Sciences Inc (2) | 0.13 | News Release200 | RepliCel Life Sciences has no material changes |
2023-09-27 19:28 | CC:RP | RepliCel Life Sciences Inc (2) | 0.13 | News Release200 | RepliCel shareholders approve equity incentive plan |
2023-09-13 16:13 | CC:RP | RepliCel Life Sciences Inc (2) | 0.13 | News Release200 | RepliCel Life Sciences has no material changes |
2023-09-13 11:46 | CC:RP | RepliCel Life Sciences Inc (2) | 0.13 | News Release200 | RepliCel Life receives DermaPrecise testing data |
2023-08-30 19:36 | CC:RP | RepliCel Life Sciences Inc (2) | 0.15 | News Release200 | RepliCel misses Q2 results filing deadline |
2023-08-25 17:15 | CC:RP | RepliCel Life Sciences Inc (2) | 0.13 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-08-25 17:15 | CC:RP | RepliCel Life Sciences Inc (2) | 0.13 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-08-16 20:05 | CC:RP | RepliCel Life Sciences Inc (2) | 0.15 | News Release200 | RepliCel Life Sciences CFO Ma dies |
2023-08-09 17:52 | CC:RP | RepliCel Life Sciences Inc (2) | 0.155 | News Release200 | RepliCel to hold AGM on Sept. 22 |
2023-08-09 14:03 | CC:RP | RepliCel Life Sciences Inc (2) | 0.155 | News Release200 | RepliCel Life Sciences appoints Mackay as director |
2023-06-15 20:29 | CC:RP | RepliCel Life Sciences Inc (2) | 0.24 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2023-06-15 20:29 | CC:RP | RepliCel Life Sciences Inc (2) | 0.24 | SEDAR MD & A815 | SEDAR MD & A |
2023-05-30 14:44 | CC:RP | RepliCel Life Sciences Inc (2) | 0.21 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-30 14:44 | CC:RP | RepliCel Life Sciences Inc (2) | 0.21 | SEDAR MD & A815 | SEDAR MD & A |
2023-05-17 20:16 | CC:RP | RepliCel Life Sciences Inc (2) | 0.17 | Miscellaneous270 | RepliCel Life 2,109,234 warrants extended |
2023-05-17 20:12 | CC:RP | RepliCel Life Sciences Inc (2) | 0.17 | Miscellaneous270 | RepliCel Life 4,209,825 warrants extended |